Applications of 4-Piperidin-1-Yl-Benzoic Acid in Industrial Manufacturing

4-Piperidin-1-Yl-Benzoic Acid serves as a highly specialized intermediate in a select range of advanced manufacturing processes, supporting formulation innovation and consistent quality in chemical synthesis, pharmaceutical production, and materials science. The following application scenarios provide precise integration details for downstream industries, including compliance, dosing ratios, process steps, and end product categories.

1. Active Pharmaceutical Ingredient (API) Intermediate for CNS Agents

In the pharmaceutical sector, this compound functions as a vital building block for synthesizing central nervous system (CNS) therapeutics, particularly certain classes of antipsychotics and antidepressants. Regulatory bodies enforce stringent guidelines for both synthesis and traceability due to the sensitivity of downstream actives. Precise formulation input helps to maximize yield of final APIs while ensuring downstream process purification meets pharmacopoeial requirements.

Industry compliance standards

• ICH Q7 Good Manufacturing Practice for Active Pharmaceutical Ingredients
• U.S. Pharmacopeia (USP) relevant monographs for API synthesis
• European Pharmacopoeia (Ph. Eur.) guidelines for raw ingredient traceability
• 21 CFR Part 211 (FDA) for finished pharmaceuticals

Typical usage ratio

• Employed at 0.2–1.5 molar equivalents relative to the primary substrate, adjusted based on target molecule yield and impurity profile.

Downstream process integration

• Incorporated during Stage II of the condensation reaction, following initial scaffold assembly, prior to final cyclization or salt formation.

Final product types

• API intermediates for CNS drugs (e.g., new-generation antipsychotics)
• Finished APIs dispatched for oral tablet and injectable formulation

2. Synthesis of Agrochemical Active Substances

This compound enables the production of specific crop protection actives belonging to the piperidine and benzoic acid derivative families. Manufacturers focus on ensuring precise stoichiometry to avoid by-product contamination, as regulatory auditing and downstream formulation consistency are critical for agrochemical registration and safety.

Industry compliance standards

• FAO/WHO JMPR Guidelines for pesticide ingredients
• ISO 9001 quality system for agrochemical synthesis
• REACH Regulation (EU) No 1907/2006 for chemical safety
• GB 3796-2019 (China) General rules for pesticide formulations

Typical usage ratio

• Applied at 0.5–2.0 wt% of batch size, matched to the theoretical yield target for the active's core structure

Downstream process integration

• Added as a coupling reactant during active substance framework assembly, ahead of post-condensation purification and isomer separation

Final product types

• Precursor compounds for selective herbicides and insecticides
• Active ingredient concentrates for formulation into EC, SC, or WG pesticides

3. Chemical Intermediate in Advanced Polymer Modification

The aromatic piperidine structure supports the synthesis of specialized monomers and crosslinking agents, which downstream polymer producers use to tailor thermal, mechanical, or UV resistance properties in advanced materials. Process engineers rigorously monitor dosage to avoid over- or under-crosslinking during polymerization, meeting sector-specific quality expectations.

Industry compliance standards

• ISO 9001, ISO 14001 for quality and environmental management in polymer manufacture
• EU Regulation No 10/2011 (Plastic FCM) for food contact materials, if applicable
• ASTM D2563 (for structural plastics and composites)
• RoHS 3 (Directive 2015/863) for electronics-grade polymers

Typical usage ratio

• Usually 0.2–1.0 phr (parts per hundred resin) in the modification phase, empirically adjusted to polymer backbone reactivity and performance specification

Downstream process integration

• Charged into the monomer mixture prior to thermal or photochemical initiation of polymer chain growth, enabling controlled matching to grade requirements

Final product types

• Specialty engineering plastics with enhanced durability
• Modified coatings and adhesives for electronics or automotive applications

4. Intermediate for Specialty Dye and Pigment Manufacturing

This aromatic piperidine-carboxylic acid compound contributes core moieties for high-performance dye molecules, offering enhanced stability for textile, plastics, and ink industries. Manufacturers select incorporation points to control chromophore assembly and optimize colorfastness, while adhering to rigorous certification for consumer and industrial safety.

Industry compliance standards

• OEKO-TEX Standard 100 (for textiles dyes)
• EN 71-3 (Safety of toys - migration of certain elements)
• ISO 1833 (Textiles—quantitative chemical analysis)
• Global Organic Textile Standard (GOTS), where applicable

Typical usage ratio

• Typical input is 0.3–1.2 equivalents, proportioned against the primary aromatic amine in dye synthesis; adjusted for hue strength and solubility requirements

Downstream process integration

• Combined with coupling agents after initial diazotization, prior to final condensation or sulfonation to ensure stable integration into dye chromophores

Final product types

• Specialty reactive and disperse dyes for textile mills
• Colorants for technical inkjets and plastics coloration

5. Intermediate for Fine Chemical Synthesis and Medicinal Chemistry

R&D laboratories and fine chemical manufacturers rely on this compound in multi-step synthesis routes for heterocyclic scaffolds and molecular probes. The aromatic-piperidinyl structure enables route optimization in customized projects, with close monitoring of reaction kinetics and analytical traceability as required by the highly regulated research environment for medicinal chemistry.

Industry compliance standards

• GLP (Good Laboratory Practice) for research and diagnostics
• ISO 17034 for reference material producers
• REACH registration in experimental or pilot-scale synthesis (if >1T/year)
• ICH Q9 Risk Management for pharmaceutical R&D processes

Typical usage ratio

• Variable, from 1.0–2.5 equivalents per reaction step; optimized based on desired substitution pattern and downstream purification constraints

Downstream process integration

• Introduced during key intermediate formation in multi-step syntheses, prior to functional group transformations or ring closure

Final product types

• Reference standards for analytical laboratories
• Proprietary scaffolds and intermediates for medicinal chemistry campaigns